Physician
Ophthalmology
Dr. Karl G. Csaky, MD
|
|
Give Review
Karl G. Csaky, MD is an expert in the field of Ophthalmology. He attended University of Louisville School of Medicine. University of Louisville School of Medicine is ranked 83/0 in Research/PrimaryCare. He has 2 awards "CMS Meaningful Use Stage 1 Certification" and "Fellow (FAAO)". Karl G. Csaky, MD is also a published doctor. He has 45 publication published. The most recent publication is: Inclusion of Genotype with Fundus Phenotype Improves Accuracy of Predicting Choroidal Neovascularization and Geographic Atrophy. He accepts all Medicare patients.
Publications
- Inclusion of Genotype with Fundus Phenotype Improves Accuracy of Predicting Choroidal Neovascularization and Geographic Atrophy.
- Clinical Classification of Age-Related Macular Degeneration.
- SU5416 induces premature senescence in endothelial progenitor cells from patients with age-related Macular degeneration.
- Ophthalmic drug delivery systems for the treatment of Retinal diseases: basic research to clinical applications.
- Evaluation of clearance mechanisms with transscleral drug delivery.
- Cigarette smoke-related hydroquinone induces filamentous actin reorganization and heat shock protein 27 phosphorylation through p38 and extracellular signal-regulated ...
- Vitreous VEGF clearance is increased after vitrectomy.
- Investigating the movement of intravitreal human serum albumin nanoparticles in the vitreous and Retina.
- FcRn receptor-mediated pharmacokinetics of therapeutic IgG in the eye.
- Late outgrowth endothelial progenitor cells in patients with age-related Macular degeneration.
- Mapping of the neonatal Fc receptor in the rodent eye.
- Drug elimination kinetics following subconjunctival injection using dynamic contrast-enhanced magnetic resonance imaging.
- Report from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium.
- Angiogenesis inhibition and choroidal Neovascularization suppression by sustained delivery of an integrin antagonist, EMD478761.
- A pharmacokinetic and safety evaluation of an episcleral cyclosporine implant for potential use in high-risk keratoplasty rejection.
- Assessment of subconjunctival and intrascleral drug delivery to the posterior segment using dynamic contrast-enhanced magnetic resonance imaging.
- An apolipoprotein E variant may protect against age-related Macular degeneration through cytokine regulation.
- A novel bioerodible deep scleral lamellar cyclosporine implant for uveitis.
- Safety and pharmacokinetics of a preservative-free triamcinolone acetonide formulation for intravitreal administration.
- Intravitreal injection of triamcinolone acetonide for immune recovery uveitis.
- Effective transscleral delivery of two Retinal anti-angiogenic molecules: carboxyamido-triazole (CAI) and 2-methoxyestradiol (2ME2).
- Serum inflammatory markers in Diabetic retinopathy.
- Differences in gene expression profiles in dermal fibroblasts from control and patients with age-related Macular degeneration elicited by oxidative injury.
- Nonlethal oxidant injury to human Retinal pigment epithelium cells causes cell membrane blebbing but decreased MMP-2 activity.
- Central visual function and the NEI-VFQ-25 near and distance activities subscale scores in people with type 1 and 2 diabetes.
- Preclinical evaluation of a novel episcleral cyclosporine implant for ocular graft-versus-host disease.
- Study of ocular transport of drugs released from an intravitreal implant using magnetic resonance imaging.
- Analysis of Hemicentin-1, hOgg1, and E-selectin single nucleotide polymorphisms in age-related Macular degeneration.
- Cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma: a new cause of uveitis.
- Survival of Retinal pigment epithelium after exposure to prolonged oxidative injury: a detailed gene expression and cellular analysis.
- The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related Macular degeneration.
- Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging.
- Intravitreal injection of triamcinolone for diffuse Macular edema.
- Monocyte activation in patients with age-related Macular degeneration: a biomarker of risk for choroidal neovascularization?
- FibroVascular changes misdiagnosed as cytomegalovirus retinitis reactivation in a patient with immune recovery.
- Bone marrow-derived progenitor cells contribute to experimental choroidal Neovascularization.
- Identification of well-defined intrachoroidal Neovascularization by high-speed indocyanine green angiography.
- The long-term effects of laser photocoagulation treatment in patients with Diabetic retinopathy: the early treatment Diabetic retinopathy follow-up study.
- Macrophage depletion diminishes lesion size and severity in experimental choroidal Neovascularization.
- In vivo gene transfer as a means to study the physiology and morphogenesis of the Retinal pigment epithelium in the rat.
- Extensive Retinal neovascularization as a late finding in human immunodeficiency virus-infected patients with immune recovery uveitis.
- Regulation of estrogen receptors and MMP-2 expression by estrogens in human Retinal pigment epithelium.
- Age as an independent risk factor for severity of experimental choroidal Neovascularization.
- Fluorescein angiographic findings in primary intraocular lymphoma.
Schools
University Of Louisville
Duke University
Wash University Barnes Hospital
Johns Hopkins University And Hospital
Procedures Preformed
- Repair of Retinal Detachment
- Repair of Retinal Detachment or Retinal Tear
Conditions Treated
- Diabetic Macular Edema (DME)
- Diabetic Retinopathy
- Floaters
- Macular Degeneration
- View All
Doctors Specialties
- Ophthalmology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FAAO)
Education
-
Washington University - Barnes-Jewish Hospital -
Duke University Hospital -
University of Louisville School of Medicine
Hospital
-
Duke University Hospital
Drug Facts
| NPI NUMBER | 1144375122 | |
| NPPES Provider LastName | CSAKY | |
| NPPES Provider FirstName | KARL | |
| NPPES Provider ZIPCode | 752315078 | |
| NPPES Provider State | TX | |
| Specialty Description | Ophthalmology | |
| Total Claim Count | 38.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1144375122 |
| Last Name Of The Provider | CSAKY |
| First Name Of The Provider | KARL |
| View All |
Similar Doctors
|
Dr. Robert M. Tenery Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael S. Harris, MD |
|
|
Dr. Davinder S. Grover, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kamel M. Itani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Florence G. Braun, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Glenn L. Walker, MD |
|
|
Dr. Carol F. Zimmerman, MD |
|
|
Dr. Christopher T. Lee, MD |
|
|
Dr. Cedric C. Adams, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edra S. Abramson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lawrence O. Gahagan, MD
This Doctor is OpenDoctor Recommended.
|